Propafenone-induced acute cholestatic hepatitis. Report of a case and review of the literature;Epatite acuta colestatica da propafenone. Descrizione di un caso e revisione della letteratura

Recenti Progressi in Medicina

Volumn 92, Issue 3, 2001, Pages 197-199

  Gandolfi, Alberto ^a   Rota, Edda ^a   Zanghieri, Gianni ^a   Tolomelli, Stefano ^a   Bagnulo, Alberto ^a   Mengoli, Marco ^a  

^a NONE

Author keywords

Acute cholestatic hepatitis; Drug induced liver disease; Propafenone

Indexed keywords

PROPAFENONE;

ADULT; ARTICLE; CASE REPORT; CHOLESTATIC HEPATITIS; DRUG WITHDRAWAL; HUMAN; LIVER FAILURE; LIVER TOXICITY; MALE;

ACUTE DISEASE; ANTI-ARRHYTHMIA AGENTS; CHOLESTASIS, INTRAHEPATIC; HEPATITIS, TOXIC; HUMANS; MALE; MIDDLE AGED; PROPAFENONE;

EID: 0035044570     PISSN: 00341193     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Danan G, Benhamou JP. Les atteintes hépatiques médicamenteuses. Presse Méd 1986; 20: 909-10.
2. Jones JK. Suspected drug-induced hepatic reactions reported to the FDA's adverse reaction system: an overview. Sem Liver Dis 1981; 1: 157-62.
3. Knill-Jones RP. Stem DEI, Girmes DH, Maxwell JD, Thompson RPH, Williams R. Use of sequential bayesian model in diagnosis of jaundice by computer. Br Med J 1973; 1: 530-3.
4. Biour M, Poupon R, Grange JD, Chazouillères O, Lévy VG, Jaillon P. Hépatotoxicité des médicaments. Gastroenterol Clin Biol 1997; 21: 660-96.
5. Lee AU, Farrell GC. Drug-induced liver disease. Current Opinion in Gastroenterology 1997; 13: 199-205.
6. Kane JA, Kane SP, Jain S. Hepatitis induced by traditional Chinese herbs: possible toxic components. Gut 1995; 36: 146-7.
7. Gordon DW, Rosenthal G, Hart J, Sirota R, Baker AL. Chaparral ingestion: the broadening spectrum of liver injury caused by herbal medications. JAMA 1995; 273: 489-90.
8. Mattei A, Rucay P, Samuel D, Feray C, Michel R, Bismuth H. Liver transplantation for acute liver failure after herbal medicine (Teucrium polium) administration. J Hepatol 1995; 22: 597.
9. Larrey D. Drug-induced hepatitis: epidemiologic, clinical, diagnostic and physiopathologic aspects in 1995. Rev Méd Interne 1995; 15: 752-8.
10. Klatskin G.Toxic and drug-induced hepatitis.In: Diseases of the liver (Schiff L ed). Philadelphia: Lippincott 1975: 604-710.
11. Hautekeete ML, Kockx MM, Naegels S, Holvoet JK, Hubens H, Kloeppel G. Cholestatic hepatitis related to quinolones: a report of two cases. J Hepatol 1995; 23: 759-63.
12. Pott G. Drug-induced cholestasis. Z Gastroenterol 1993; 31 (suppl 2P): 73-5.
13. Bryson RM, Palmer M, Langtry HD, Fitton A. Propafenone. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in cardiac arrhythhmias. Drugs 1993, 45: 85-130.
14. Schlepper M. Propafenone, a review of its profile. Eur Heart J 1987; 8 (suppl A): 27-32.
15. Spinler SA, Elder CA, Kindwall KE. Propafenone-induced liver injury. Ann Pharmacother 1992; 26: 926-8.
16. Elizalde JI, Bataller R, Bruix J, Rodes J. Propafenone hepatotoxicity. Gastroenterol-Hepatol 1994; 17: 382-3.
17. Mondardini A. Pasquino P, Bernardi P, Aluffi E, Tartaglino B. Mazzucco G, Bonino F, Verme G, Negro F. Propafenone-induced liver injury: report of a case and review of the literature. Gastroenterology 1993; 104: 1524-6.
18. Schueppel R, Probst M. Acute cholestatic hepatitis and the sudden rise of the pacing threshold 5 weeks after VVI-pacemaker implantation. J Int Med 1994; 236: 353-6.
19. Criteria of drug-induced liver disorders. Report of an international Consensus Meeting. J Hepatol 1990; 11: 272-6.
20. Mayoral W, Lewis JH, Zimmerman H. Drug-induced liver disease. Current Opinion in Gastroenterology 1999; 15: 208-16.